Pharm Exec1d
FDA Approves SpringWorks Therapeutics’ Gomekli for Neurofibromatosis Type 1, Symptomatic Plexiform Neurofibromas
Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1 ...
manilatimes2d
SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
Staffordshire hospital trust tells residents with flu, vomiting and diarrhoea to keep away to ease winter pressures
A Staffordshire acute hospital trust has reported dozens of cases of the sickness bug norovirus in the past month as it ...